A sequence variation: 713-8delC in the transforming growth factor beta 1 gene polymorphism in thalassemia major patients

Journal of Clinical Densitometry

Volumn 17, Issue 1, 2014, Pages 185-189

  Singh, Kritanjali ^a   Agarwal, Sarita ^a   Shukla, Anju ^a   Gupta, Sushil ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

BMD; DXA; PTH

Indexed keywords

BMD; DXA; PTH;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; BETA-THALASSEMIA; BLOOD TRANSFUSION; BONE DENSITY; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FEMUR; HUMANS; INDIA; LUMBAR VERTEBRAE; MALE; OSTEOPOROSIS; POLYMORPHISM, GENETIC; RADIUS; SEQUENCE DELETION; TRANSFORMING GROWTH FACTOR BETA1; YOUNG ADULT;

EID: 84895045141     PISSN: 10946950     EISSN: 15590747     Source Type: Journal    
DOI: 10.1016/j.jocd.2013.04.004     Document Type: Article

References (37)

1. Vichinsky E.P. The morbidity of bone disease in thalassemia. Ann N Y Acad Sci 1998, 850:344-348.
2. Domrongkitchaiporn S., Sirikulchayanonta V., Angchaisuksiri P., et al. Abnormalities in bone mineral density and bone histology in thalassemia. J Bone Miner Res 2003, 18:1682-1688.
3. Rachmilewitz E.A., Giardina P.J. How I treat thalassemia. Blood 2011, 118:3479-3488.
4. Morabito N., Lasco A., Gaudio A., et al. Bisphosphonates in the treatment of thalassemia-induced osteoporosis. Osteoporos Int 2002, 13:644-649.
5. Molyvda-Athanasopoulou E., Sioundas A., Karatzas N., et al. Bone mineral density of patients with thalassemia major: four-year follow-up. Calcif Tissue Int 1999, 64:481-484.
6. Pocock N.A., Eisman J.A., Hopper J.L., et al. Genetic determinants of bone mass in adults: a twin study. J Clin Invest 1987, 80:706-710.
7. Slemenda C.W., Christian J.C., Williams C.J., et al. Genetic determinants of bone mass in adult women: a revaluation of the twin model and the potential importance of gene interaction on heritability estimates. J Bone Miner Res 1991, 6:561-567.
8. Soroko S.B., Barret-Connor E., Edelstein S.L., Kritz-Silverstein D. Family history of osteoporosis and bone mineral density at the axial skeleton: the Rancho Bernardo Study. J Bone Miner Res 1994, 9:761-769.
9. Morrison N.A., Qi J.C., Tokita A., et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994, 367:284-287.
10. Grant S.F.A., Reid D.M., Blake G., et al. Reduced bone density and osteoporosis associated with a polymorphic Spl binding site in the collagen type a1 gene. Nat Genet 1996, 14:203-205.
11. Kobayashi S., Inoue S., Hosoi T., et al. Association of bone mineral density with polymorphism of the oestrogen receptor gene. J Bone Mineral Res 1996, 11:306-311.
12. Masi L., Becherini L., Colli E., et al. Polymorphism of the calcitonin receptor gene are associated with bone mineral density in postmenopausal Italian women. Biochem Biophys Res Commun 1998, 248:190-195.
13. Derynck R., Jarrett J.A., Chen E.Y., et al. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 1985, 316:701-705.
14. Bonewald L.F., Mundy G.R. Role of transforming growth factor-beta in bone remodeling. Clin Orthop Relat Res 1990, 250:261-276.
15. Langdahl B.L., Knudsen J.Y., Jensen H.K., et al. A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 1997, 20:289-294.
16. Bertoldo F., D'Agruma L., Furlan F., et al. Transforming growth factor-beta1 gene polymorphism, bone turnover, and bone mass in Italian postmenopausal women. J Bone Mineral Res 2000, 15:634-639.
17. Perrotta S., Cappellini M.D., Bertoldo F., et al. Osteoporosis in beta-thalassaemia major patients: analysis of the genetic background. Br J Haematol 2000, 111:461-466.
18. Poncz M., Solowiejczyk D., Harpel B., et al. Construction of human gene libraries from small amounts of peripheral blood: analysis of beta-like globin genes. Hemoglobin 1982, 6:27-36.
19. Pocoit F., Hansen M.P., Karlsen A.E., et al. TGF-beta1 gene mutation in insulin-dependent diabetes mellitus and diabetic nephropathy. J Am Soc Nephrol 1998, 9:2302-2307.
20. Krall E.A., Dawson-Hughes B. Heritable and life-style determinants of bone mineral density. J Bone Miner Res 1993, 8:1-9.
21. Peacock M. Vitamin D receptor gene alleles and osteoporosis: a contrasting view. J Bone Miner Res 1995, 10:1294-1297.
22. Han K.O., Moon I.G., Kang Y.S., et al. Nonassociation of oestrogen receptor genotypes with bone mineral density and estrogens responsiveness to hormone replacement therapy in Korean postmenopausal women. J Clin Endocrinol Metab 1997, 82:991-995.
23. Yamada Y., Miyauchi A., Goto J., et al. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Mineral Res 1998, 13:1569-1576.
24. Olivieri N.F. The beta-thalassemia. N Engl J Med 1999, 341:99-109.
25. Cooley T.B., Witwer E.R., Lee P. Anemia in children with splenomegaly and peculiar changes in bones. Am J Dis Child 1927, 34:347-363.
26. Giardina P.J., Schneider R., Lesser M., et al. Abnormal bone metabolism in thalassaemia. Endocrine Disorders in Thalassemia 1995, 39-46. Springer, Berlin, Germany. S. Ando (Ed.).
27. Jensen C.E., Tuck S.M., Agnew J.E., et al. High prevalence of low bone mass in thalassaemia major. Br J Haematol 1998, 103:911-915.
28. Dresner Pollak R., Rachmilewitz E., Blumenfeld A., et al. Bone mineral metabolism in adults with beta-thalassaemia major and intermedia. Br J Haematol 2000, 111:902-907.
29. Ferrara M., Matarese S.M., Francese M., et al. Effect of VDR polymorphisms on growth and bone mineral density in homozygous beta thalassaemia. Br J Haematol 2002, 117:436-440.
30. El-Edel R.H., Ghonaim M.M., Abo-Salem O.M., El-Nemr F.M. Bone mineral density and vitamin D receptor polymorphism in beta-thalassemia major. Pak J Pharm Sci 2010, 23:89-96.
31. Hamed H.M., Galal A., El Ghamrawy M., et al. Vitamin D receptor polymorphisms and indices of bone turnover and bone mass in Egyptian children with sickle cell disease. Res J Med Med Sci 2010, 5:1-7.
32. Nakamura K., Ueno K., Nishiwaki T., et al. Nutrition, mild hyperparathyroidism, and bone mineral density in young Japanese women. Am J Clin Nutr 2005, 82:1127-1133.
33. Vupputuri M.R., Goswami R., Gupta N., et al. Prevalence and functional significance of 25-hydroxyvitamin D deficiency and vitamin D receptor gene polymorphisms in Asian Indians. Am J Clin Nutr 2006, 83:1411-1419.
34. Frisk P., Arvidson J., Ljunggren O., Gustafsson J. Decreased bone mineral density in young adults treated with SCT in childhood: the role of 25-hydroxyvitamin D. Bone Marrow Transplant 2011, 47:657-662.
35. Pirinççioǧlu A.G., Akpolat V., Köksal O., et al. Bone mineral density in children with beta-thalassemia major in Diyarbakir. Bone 2011, 49:819-823.
36. De Sanctis V., Borsari G., Brachi S., et al. A rare cause of heart failure in iron-overload thalassaemic patients-primary hypoparathyroidism. Georgian Med News 2008, 156:111-113.
37. Chatterton B.E., Thomas C.M., Schultz C.G. Liver density measured by DEXA correlates with serum ferritin in patients with beta-Thalassemia Major. J Clin Densitom 2003, 6:283-288.